(Q41677313)

English

The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study

scientific article published on 5 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 October 2017

The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study (English)

1 reference

Europe PubMed Central

6 October 2017

0 references

1 reference

based on heuristic

inferred from title

Escherichia coli

object named as

Escherichia coli

1 reference

based on heuristic

inferred from title

author name string

S J M Ten Bruggencate

1

1 reference

Europe PubMed Central

6 October 2017

S A Girard

2

1 reference

Europe PubMed Central

6 October 2017

E G M Floris-Vollenbroek

3

1 reference

Europe PubMed Central

6 October 2017

R Bhardwaj

4

1 reference

Europe PubMed Central

6 October 2017

T A Tompkins

5

1 reference

Europe PubMed Central

6 October 2017

publication date

5 November 2014

1 reference

Europe PubMed Central

6 October 2017

European Journal of Clinical Nutrition

1 reference

Europe PubMed Central

6 October 2017

69

1 reference

Europe PubMed Central

6 October 2017

3

1 reference

Europe PubMed Central

6 October 2017

385-391

1 reference

Europe PubMed Central

6 October 2017

https://scigraph.springernature.com/pub.10.1038/ejcn.2014.238

0 references

Travel and migration associated infectious diseases morbidity in Europe, 2008.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Diarrhoea associated with antibiotic use.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Assessment of bacterial antibiotic resistance transfer in the gut.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Meta-analysis of probiotics for the prevention of traveler's diarrhea

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Effects of Saccharomyces boulardii in children with acute diarrhoea

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats : preventive effects of probiotics on TD.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Diarrhea caused by enterotoxigenic Escherichia coli infection of humans is inhibited by dietary calcium.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC).

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Traveler's Diarrhea.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Drug prophylaxis for travelers' diarrhea

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Recent advances in understanding enteric pathogenic Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2014.238

21 January 2018

Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary fructooligosaccharides affect intestinal barrier function in healthy men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25369827

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/EJCN.2014.238

1 reference

Europe PubMed Central

6 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41677313&oldid=1925857259"